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The importance of nitric oxide (NO) in mediating 
macrophage functions has been demonstrated, but 
production of this potent gas has not been examined 
in Langerhans cells (LC). Using murine LC purified 
from epidernlal cell suspensions and the recently 
established LC-like cell line derived from newborn 
BALBI c epidermis (XS-52), it was shown with reverse 
transcriptase (RT)-PCR that inducible nitric oxide 
synthase (iNOS) message is present in these cells. 
Murine keratinocytes did not contain iNOS message. 
iNOS 111RNA was increased in a conc~ntration-de­
pendent manner by lipopolysaccharide (LPS) in puri-
fie d ttl.urine LC and XS-52 cells. and i111munofluores-
cence using an antibody to iNOS revealed bright 
cytoplasmic staining in LPS-treated XS-S2 cells . An-
ti-iNOS antibody brightly stained LC on hunlan neo-
L angerhan s ce ll s (LC) arc dendritic cells of the skin that play an important role in cutaneous immune responses (Kapsenberg Cl (/1 , 1990) . Their fun ction is to sample, respond, an.d to inform the rest of ~he immune sys~elll of changes 111 the enviro nme n t (Stell1man, "1 991.; Kim-
ber and C umberbatch , 1992). LC res ide in the basal and suprabasa l 
layers of the e pide rmis and form a ne two rk of dendrites, through 
whi c h t h ey inte rac t w ith adjacent kera tinocytes (Kaplan e/ ai, 1992) 
and nerves (H osoi cl ai, 1993) . They are m obile and can migrate to 
the T cell-dependent area ofl ymph nodes (Si lbe rberg-S inakin ct ai, 
1976). L ike m acro phages, they arc myelo id in o rigin, consti tu tive ly 
eX'Press maj o r histocompatibility cOlllplex-lI, an d have potent 
antigen-presenting properties (S ting l. 1990). Unlike macrophages. 
however, LC have the abili ty to sen sitize na'ive T cells (Peguet-
Nava rro, 1994). Majo r hurdles in the study of LC fun ction include 
the inability to grow these cells in cul ture and the absence of LC 
cell lines. Part of this proble m has been solved with the availability 
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natal foreskin cryosections. An increase in NO pro-
duction by LPS-treated XS-S2 cells over 16 h. as 
nleasured by the deternlination of nitrite levels in 
culture supernatants using the Griess Reaction. was 
observed. Interferon-y (IFNI') did not affect NO pro-
duction on its Own. In the presence ofLPS and IFNI'. 
NO production was 3 times 1110re than observed with 
LPS alone. NO production was inl1ibited by the NOS 
inhibitor L-NAME. Western blots with anti-iNOS 
antibody demonstrated an increase in iNOS expres-
sion in LPS-treated XS-S2 cells that was suppressed 
by IL-l0. NO produced in LC may affect LC functions 
such as microbicid~l activity. antigen presentation, 
and cytotoxicity and may affect adjacent kera tino-
cytes and melanocytes. K ey wOl'ds: IIIollse!delldl'itic cells! 
L-NAME. ] II/vest Del'/l/atol 107:815- 821, 1996 
of the XS series of LC-like cell lili es (Takashim a CI ai, 1995; XU ('I 
al. 1995a, 1995b). 
In 198 '1, Tannenbaum fOllnd that a patie n t who suffered from 
infectio us diarrhea excreted vel)' hj gh le ve ls of urinary nilT3tes. 
opening the door to a series of investigatio ns that resulted in the 
d.iscovery of ni tric oxide (NO) in m acrophages (Snyder and Bredt, 
1992). It is now known that macrophages express an indu cibl e 
isoform of the e nzym e ni tric oxide syn thase (iN OS); the iNOS 
gen e has been cloned, the expressio n of which is dramatically 
increased in the presence of the endotoxin. lipopolysaccharide 
(LPS) (Lyons ('/ ai, 1992; Xie el ai, 1992) . iNOS is responsibl e fo r 
converting L-a rg inine in to N O via a se ries of reactions jnvolving 
co-f;lc tors such as tetra hyd robiopterin (M il ste in cr ai, 1993; Nathan 
and Xie, 1994). NO is a sho rt-lived. highly reactive gas that has the 
abili ty to dif!i.lse across cells (Lancaster, J 994) and afrect neighbor-
in g ce ll s. T hus N O may produce effects distan t to its site of 
production. NO is potentiall y tox ic and has rich redox and additive 
che mical properties (Stamler ct ai, 1992) that allow it to exert 
paradoxical efrects in re lated biologic system s, e.g., NO has been 
shown to m ediate both servoregllia to ry and cytotox ic fu nctions 
(Nathan , '1992). It has been identiJied as a mediator in vasodilata -
tion (Pa lmer ct ai, 1987), as a neurotransmitter in th e cen tra l and 
periphe ral nervous systems (Edelman and Gaily. 1992) . and as an 
active agent in macrophage cytotoxicity (Liew 1'1 ai, 1990; C unha ct 
al. 1993) and neurotoxjcity. NO fi'olll macrophages has been 
implicated in the no nspecific de fe nse aga inst parasitic disease (Lie", 
alld Cox, 'j 99 1) as it participates in the productio n of /Tee radicals 
that are direc tly toxic to bacteria and parasites. 
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Regulation of NO prod uction occurs at multiple stages, such as 
iN OS mRNA transcription, stability , and translation ; LPS upregu-
lates and interleukin-l0 down-regulates iNOS transcription in 
macrophages (Nathan, 1992) . At the protein level, iNOS m ay b e 
regulated by calmodulin , dimer formation (dimers of NOS are its 
functiona Uy active form), L-arginine depletion or competitive 
inhibition by L-arginine h o mologs (N",-nitro-L-arginine methyl 
ester [L-NAMEl) , end-product inhibition (NO inhibits NOS tran-
scriptio n). and co-f.,ctor availability (tetl"ahydrobioptel;n is an 
important co-factor). 
Despite the rapid pmgress in NO biology research, few studies 
descl'ibing the role of NO in skin have been published (Qureshi ef 
aI, 1996). NO has been shown to play a mle in c utaneOll S 
vasodilatory responses (KJlan ef aI, 1993), Substance P-i.nduced 
edema formation in mOllse skin (Hughes ef aI, 1990), and mustard 
oil-induced inflammation in rat skin (Lippe ef aI, 1993) . It has been 
suggested that NO may be involved in psoriasis (Kolb-Bachofen ef 
aI, 1994) and atopic dermatitis (Modta et aI, 1995). The presence of 
iN OS and production of NO by ceUs in the epide rmis other than 
LC is sti ll under i.nvestigation. It has been reported that interferon-y 
(IFNy) ca uses keratinocytes to produce NO (Heck ef (II, 1992), 
implying that iN OS was present in these cell s, but NOS regulation 
was not examin ed. Other reports indicate that NO is produced in 
keratinocytes stimulated by ultraviolet ligh t (Deliconstatinos et (II, 
1995) or activation of FcERll by CD23 (Becker, 1993) or is 
produced by a con stituti ve form of NOS (Baudoin and Tachon, 
1996). NO may ha ve a ro le in ultra viol et Ligh t-dependent cutane-
ous vasodilati on (Warren , 1994), and there is a sin g le report of 
upregulation of iN OS message in pati ents with psoriasis, but little 
data were provided (Kolb-Bachofen ef al. 1994). It has also b een 
shown that dermal fibroblasts express con stitutive and inducible 
forms of NOS (Wang et aI, 1996). 
T he skin is the first defense again st a hostile e nviro nment. LC 
form the afferent arm of the immun e system in the skin . In the 
epidermis, although m acroph ages can be recruited, the Lange rhan s 
ce ll is the major residen t antigen-presenting celJ. As NO is an 
important effector molecule in macro'phages, it was logica l to 
in vestigate LC for cxpression of NOS and production of NO. 
MATER.IALS AND METHODS 
Animals Eight to 12-wk-old 13ALB/c micc we re obta in cd from T he 
Jackson Laboratory (Bar Harbor, ME) for prep:lration of LC. Newborn 
SCHear luice used for the preparation or pritnary kcratinocytc c ultures were 
ki ndl y provided by Dr. Janice Brissette. 
Tissue Culture Reagel1ts, Medium, and Chc.nicals T isslle culture 
reagents were obta ined rrom Mediatech (Cellgro) Inc. (Herndon, VA) or 
Life Technologies (Grand Island. NY); complete medium consisted of 
R.PMI 1640 (certified endotoxin content < 0. 125 ng pcr ml) supplemented 
with 10')'0 feta l bovine serum, HEPES ('10 111M), streptomycin (100 J.l.g per 
ml). penicillin (100 IU per ml). 2-mercapto-ethano l (0 .1 M), sodinm 
pyruvate (1 mM), nonessenti al amino acids (0.1 mM), and L-glutam ine (2 
mM). Recombinant mln'ine IfN-y. tumor necrosis f.1ctor-a (TNfa), and 
in terleukin-10 (I L-J 0) wcre obtained fi'om Biosource International (Cam-
ari llo. CAl and L-NAME. Nw-nitro-D-arginine methyl estcr (D-NAME). 
and LPS (Escherichin (" Ii , serotype 026:136) were obtaincd fro lll Sigma (St. 
Louis. MO). 
Antibodies and re\;1ted reagents were obtained as follows: anti-Thy-1.2 
monoclonal antibody (Sigma) , low-toxicity rabbi t complement (Cedarla ne. 
Hornby, Ontario, Canada), mouse anti-mouse I-A" (PharmiJlgen, San 
Diego, CAl, goat anti-mouse IgG conjugated to magnetic microspheres 
(Dynabeads M-4S0; Dynal A.S . Oslo, Norway), Lympholyte M (density 
1.0875, Cedarlane, Hornby, ON), and anti-iN OS Auorescein isothiocya-
natc-conjug:lted monoclonal 'Illtibody as well as anti-iNOS unconjugated 
antibody (lgG) to a 21-kDa protein fragment corresponding to amino acids 
961-1144 of mouse macrophage NOS (Tnlllsduction Laboratories, Lexing-
ton, KY) . All other chemicals were obta ined from Sigma . 
EC Preparation Monocellular suspensions of murine EC were prepared 
and enriched for LC as reported previously (Grabbe 1'1 01. 199 '1) to yield an 
LC content of > 90-95'Y" as determined by I-A fJ ositiv ity on a Auo resce in-
activated cell sorter (Asahina d al. 1995) . T hy-1 + cell s were depicted by 
incubation with anti-Thy- I .2 monoclonal antibody and comfJlelllcnt. Dead 
cell s were removed over Lympholyte M. Interface ce ll s were washed and 
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subjected to magnetic microsphere separation to isolate LC using mouse 
anti-11l 011SC I_Ad for 30 Inin followed by inc ubation with goat ano-111ouse 
IgG conjugated to magnetic lI1icrospheres and subjected to a magnetic field. 
Those with attached magnetic beads were designated LC. LC were cultured 
in scru lll -n'cc COI llplctc J"n cdi llll1 . 
LC-Like Cell line (XS-52) T he XS-52 cell line was established from 
newborn BALB/c epidermis. This cell line has features of LC: they are 
dendritic, arc good antigen-presenting ce ll s, and have phenotypic charac-
teristics of rreshly harvested LC (Xu cI til. 1995a); however, on electron 
microscofJY. no Birbeck granules were observed in these cells. The ceUs 
were fJropagated in RPMl 1640 containing 10% feta l bovine serum. 50 U 
recombinant 111urinc g ranulocytc-nlacrophagc colony-stil11u larillg fnctor 
(GM-CSf) per ml, and I 0% NS cell sUfJernatant (sufJe rnatant from stromal 
ce ll s cul tured from newborn BALI3/c mice). The XS-52 ce ll s wcre grown 
in complete medium without GM-CSf and NS cell supernatant for 2 d prior 
to experiments. Viability ofXS-S2 cell s was good (similar to those cultured 
in GM-CSf UfJ to 4 d) and in the fJresence of! L- 'I 0, as determined by trypan 
blue exclusion in prciinlinary cxpcrilll c nts. 
Murine Keratil10cyte Cultures Primary keralinocytes were prepared 
frolll newborn SellenI' 111icc and g rown in 1l1ininlai essentia l 111Cdiulll at 1o,," 
calcium concentrations (0.05 mM) supplemented with 4% Cbclex-treated 
fetal bovine serum as described (Hennin gs e( nl. 1980). T he cells were 
grown fo r 1.0 d in low-calcium medium before being used for n.N A 
preparation. 
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) 
fJolyA + RNA (mRNA) was extracted fj'om purified LC incubated with and 
without LPS using magnetic microsfJheres (Dynilbeads mRNA DIRECT 
kit, Dynal. Oslo. Norway), and RT-PCR. was performed (GeneamfJ RNA 
PCR kit. Perkin-Elmer. I3ranchburg. NJ). Degenerate fJrim ers (sequences 
received with thanks frolll Dr. J ohanna Wolframm. DefJartment of Cardi-
ology, Univers ity ofVicnna. Austria) designed to amplify iNOS, eeN OS, or 
neNOS, and across mouse, nit, and hllll1nn species; 5'-prinlcr (Dcg-A) , 
CAYRTCAAGTAYGCCACCAACAAAGGGAA and 3'-primer (Dcg-C), 
RCCRATCTCHGTGCYCATGTACCWllC. These primers span 419 bp 
in the 1Il0 use macrofJhage-iNOS sequence. PC ll conditions werc as fo llows. 
R T reaction: room temperature for 20 min. 42°C for 15 min. 99°C for 5 
min. and 5°C for 5 min: PCIl reaction: 94 °C for 3 min ; denaturi.ng. 94°C 
30 s; annealing, 55 °C 30 s; ex tension, 72°C I min. 40 cycles, 72°C for 7 
min, 4°C. PCR products wcre separated in 1.5% agarose gels and stained 
with cthidium bromide. The fj'agnlCnt obta ined was ge l purified. cloned 
(TA cloning kit, Invitrogen, Sorrento Valley, CAl, and sequenced (Seque-
nase 2.0, US Biochemical Corp., Ocala. fL) . 
PolyA " RNA from XS-52 ce lls was subjected to PCR with degenerate 
primers (as above) and iN OS-specific primers: 5' -primer (iNOS-A), AG-
CATCAGAGGGGATGCTGC, and 3'-primer (iNOS-C), ATCCTTCG-
GCCCACTTCCTC. These fJrilllers span 370 bfJ in the mouse macrophagc-
iN OS sequence: iNOS-A (992-'101 1 nucleotides), and iNOS-C (1362-1343 
nucleotides). T hese reactions were carried o ut in fJarallcl with glyceralde-
hyde-3-phospha te dehydrogenase (GAPDH) primers to standardize inten-
sity of bands obtained with and without LPS. After Il T reaction, the 
reaction mixture was sfJ lit for PCR for iN OS (40 cycles) and GA1'DH (25 
cycles) . Primers for GA PDH were chosen from homologous region be-
tween human. chick, and rat specics: 5'-primer (GAPDH-A). ACTACAT-
GGTTTACATGTTC, and 3'-primer (GAPDH-C), TTCCCGTTCAG-
CACTGGGATGA. for nucleotides 1.83-201 and 740-719, respectively, for 
hUlIlan GAPDH cDNA (sfJan 557 bfJ). ncNOS-specific primers were used as 
control: 5'-fJrimer (ncNOS-A). CACGTGGT CTCATTCTGAG, and 3'-
primer (ncNOS-B). TCTCTGTCCACCTGGATTCC. fo r nucleotides 
372-39 1 and 792-811. resfJectively (fJrimers sfJ'" 439 bfJ in mouse ncNOS 
sequence). 
R.NA was fJrepared fi'om primary murine keratinocytes that had been 
grown in low-calcium medium for 10 d. iN OS- , ecNOS- , and ncNOS 
fJrimcrs were used for RT-PCR.. and GAPDH primers were used as control. 
Two tyfJes of cNOS primers (ecNOS and neNOS) were used in the case of 
kcratinocytes, as it was expected tha t they would eXfJress a type of 
constituti ve NOS rather than iNOS (based on the absence of NO produc-
tion afte r LPS trcatment), and the aim was to identify the isoform of cNOS. 
Primers used were the same as above. Primers specific to eeNOS (5' - fJril1ler. 
ecNOS-E1, GGGCTCCCTCCTTCCGGCTGCCACC. and 3' -primcr. ee-
NOS-E2. GGATCCCTGGAAAAGGCGGTGAGG), which span about 280 
bp (mouse ecNOS eD NA), were obtained from Dr. Paul Huang, Massa-
chusetts Genera l HosfJitaL 
Immunoflnorescence Staining XS-S2 cells were grown for 2 d in 
eight-we ll chamber slides (Nunc Inc., NafJcrvillc. IL). washed with cold 
phosphate-buffered sa line (PBS), fixed with Illethanol:acetone (I: 1) for 5 
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min, p ermcabilizcd with 0.2% T riton Xl 00 in PBS for 20 min , and blocked 
with 2% h o rse SCrUITI . After two washes in O.2'XI bovine SCrlll11 a lbuI11in in 
PBS, anti-iN OS fluorescein isothiocyanatc was addcd to the wells at a 1:100 
dilution (2 .5 iJ.g pcr ml) and incubated at 37"C for '[ h in a one-stcp staining 
p rotocol . After thrce 10-min washes with PBS, the slidcs were mountcd 
with Gel-mount (B iomcda, Foster C ity, CAl and cxamincd using a 
microscope equipped for fluorescence. The experiment had an inherent 
negative control fo r anti- iN OS stai"ing in that ce lls not treated with LPS arc 
not stained with iNOS, and LPS-trcated cells show signifi cantl y increased 
iNOS staining. 
Inununoperoxidase Staining Cryosections of human skin , - 5 iJ.m, 
were c ut from unfixe d froze n n eona tal fo reskin specinl c lls. T he section s. 
mounted on gla ss sljdes, were fixed and penncabilized w ith acetone, 
p re inc ubatcd with 0.03'% 1-12 0 2 to inhibit endogenous peroxidase, and 
b locked with horse se rum (Vectasta in ABC kit, V cctor Laboratorics, 
Burlinghallle, CAl. After was hing with PBS, the scctions were covered wi th 
an unconjugated monoclonal anti-iNOS anti body at a 1 :120 dilution and 
kept at 4 °C ovcrnight. T he ncxt morning, aftcr washing with PBS (3 ti mcs, 
5 min each wash), bo und antibody was visualized by the avidin/ biotin-
peroxidase technique (Vcctastain ABC) according to the man ufac turer's 
instructions. 
To positive ly identi fy LC, a monoclonal ;lIIti-Lcu-GICD-l antibody 
(Becton Dickinson, San J osc, CAl was used at 5 J..I.g per 1111. Sites of antibody 
binding were idcntified as above. 
Griess Reaction (Nitrite Measurement) XS-52 cells wer<' incuba ted 
in 24-~cll plates, in both thc presence and absence of LPS (1 J..I.g per ml). 
After 24 h at 37°C, the supernatants fi'olll respective wells were assayed for 
(he prescnce of ni trite using the Griess reaction (Grcen ef nl, 1982). 
Fifcy-rnicrolitcr aliquots of cell-free supernat;lI1ts frOI1l cell s cu ltured with-
out and w ith LPS (1 J..I.g per ml) , IFNI' (200 U per ml) , IFN I' + LPS, TNFa 
(200 U per 1111) , TNFa + LPS, L-N AME (0.5-1 0 mM) + LPS, orlL-l0 (35 
and 50 ng per ml) + LPS we rc incubated with 50 J..I. I of l % sulfanilamide in 
0.5 N HCI and 50 iJ.I of 0.02%, naph thyleth ),lcnc diall1ine dihydrochloridc 
for 5 nUn at room temperature in Bat-bottom 9G-well plates. Absorbance 
was .lneasl1red at 540 nnl in an cn z),111e-linkcd inlI11UJl Osorbc Il t a.ssay 
pla te -reader. Sodiulll njtrite was used as a standard for quantifi cation of 
nitrite in culture supcrn.H:lnts. 
Western Blot with Anti-iNOS Antibody Eq ual numbers of XS- 52 
celJs (200,000 cells/well) , grown for 2 d in complete mcdiu lll without 
GM-CSF in 24-wcll plates, were treated with LPS (1 J..I.g pCI' ml), LPS + 
IL-l0 (50 ng per ml), LPS + L-NAME (5 mM), and LPS + D-NAME (5 
mM) fo r 24 h at 37°C. Cells werc examined under the microscope fo r 
viability and morphology. Subscquently, cells were washed with serum-free 
medium and boi ling sodium dodec)'1 sulf:, tc ge l- loading butter (2 X: 100 
111M Tris(hyd roxymcth yl)alllinomcthane chlo ride [pH 6.8, 200 rnM dithio-
threitol , 4% sod ium dodec)'1 sul f.1te, 0.2% bromophenol bluc, ;lI1d 20% 
glycerol) was added. T he cell s were scraped in to the buffer, tr"nsferred to 
Eppendorf tubes, and spun to remove deb,-is . Supernatants were boil ed for 
5 min, and 20-iJ.I aliquots were loaded on a 7";', polyacrylamidc gel. Prote ins 
were transferred fi'om the ge l to a po lyvin )'lidinc fluoridc membrane 
(lmll'obilon, O.4-J..I.m pore size, Milliporc, Bedford, MA) with an electro-
blotter (Transblot S]), Bio-Rad, Hercules, CAl. T he membr;lIl e was 
blocked in 'J 'X, bov ine serum albumin in was h buffer (WB: 10 111M 
Tris(h y droxy methyl)aminomcthanc [pH 7.5] , 100 mM NaCI, and 0.1 % 
Tween 20) overni ght at 4°C incuba ted with mo use anri-iN OS (1 :500) 
IgG2a m onoclonal antibody, (Transduction Laboratorics), di lu ted in 1% 
bovine serum albumin in WB fo r 1 hat rOOI1l tcmperature, and wash cd wi th 
WB over 30 min . T he secondary antibody, anti-mouse IgG (1 :3000) 
horseradish peroxidase cOl~jugate (Bio-Rad), diluted in 5% dry milk in WB, 
was incubated with agitation for 1 h at room temperature. T hc membrane 
was thoroughly washed for more than 1 h with W13 at room temperature 
and developed with ECL western blotting detection reagents (Amersham, 
Arlin gton H cights, IL) and exposed to film (X-O MAT Al l, Eas tll1 an 
Kodak, Rochester, NY). 
RESULTS 
Reverse Transcriptase-PCR Suggests the Presence of iNOS 
Transcripts in LC To examin e expressio n of NOS in LC, RNA 
was extrac ted fro m freshly purified murine LC and subjected to 
RT-PCR with d egen e rate prime rs across iNOS , ecNOS, and 
DcNOS. A band of approximately 400 bp was amplified, which was 
brighter in LPS-treated as compared to n o ntreated cell s (Fig la). 
To identify the type of NOS, the nucleotid e seq ue n ce of the PCR 
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Figure 1. PCR amplification of iNOS in LC and XS- 52 cells. 
Scanned images of 1.5% agarosc ge ls sta.ined with ctltidium bromide, (n) 
R T-PCR. on RNA fi·ol1'l purified LC shows bands at the appropriate length 
(419 bp), lower intensity in lane 1 (LPS [ - D, and hjgh"r in tensity in /rill(' 2 
(LPS[ + ]). (b) All six lanes represcnt RT-PCR. 011 R.NA from XS-52 cclls. 
Primers used arc as fo llows: Inllcs '1,2, jNOS-specific primcrs; 1m II'S 3,4, 
ncNOS-specific primers; Inll es 5,6, GA PDH primers. No PCR. product was 
sceu in Inll t' 1 (LPS[ - )) and a 370-bp band was seen in Inll e 2 (LPS I + )). 
indicating expression of iNOS message in the presence of LPS. No peR. 
product was seen in Inllt's 3 nlld 4; 557-bp fragments in lancs 5 (LPS[ - ]) and 
G (LPS[ + ]) were of equal in tensity, which serves to standardize band 
in tensi ty obtained in Inlles '1 mId 2. (c) RT-PCR on RNA from primary 
murine keratinoc)' tes grown for 10 d in low-calcium medium. Lnllt's 
1-4,LPS (- ) and Inllcs 5-8, LPS( + ). Primers used arc as follows: Inlles 1,5, 
iNOS-specific prinlcrs ; t rlllt 'S 2,6, ccNO "' -specific primers; laue." 3,7, ne-
NOS-specific primers; Inll es 4,8, GA PDH primers. PCR products were seen 
for ncNOS and GA PD H , both with and without LPS treatment. No 
evidence of iNOS or eNOS messagc was obscrved . The marker lanes 
represent a l-kb ladder. 
produc t was determined and found to be identical to mouse 
m acrophage- iN OS (data n ot shown) . 
To excl ude th e possib ili ty that NOS m essage obtain ed fi'om 
purified murine LC m ay be due to contaminating keratinocytes, o r 
other ce ll s, RNA from the ce ll line XS- S2, was subj ec ted to PCR. 
XS- 52 ce ll s have been passaged and g rown selectively in GM-CSF-
and M-CSF-rich medium to obtain a pure p opu lation of LC-li ke 
ce ll s (Takashima et aI, 1995). Degenerate NOS pr imers (data not 
sh own) and primers specific for mouse-iN OS were used (Fig lb) . 
T h c PCR product ampli fied us ing the m ouse- iN OS-specific prim-
e rs w as that of iNOS fo r the fo ll owing reason s: First, th e length of 
th e band seen o n e lectropho resis is ab om 370 nucleotides (iNOS-
specific prime rs span a 370-bp le n gth o n murine-iNOS cDNA £i-om 
m acro phages); second, the band is abscnt from cell s n ot exposed to 
LPS (iNOS express io n is induced by LPS); and third, n o produc ts 
werc seen in the n c N OS- sp ccific prime r lanes (negative co ntro l). 
I1 cNOS prime rs were sp ecifi c to the n e uro na l isofon11 of NOS and 
serve as a negative contro l. Compared to th c GAPDH standard ized 
band inte nsiti es, it appears tha t expression of the RNA in ques tion 
is LPS dependent. As m e ntio n ed above, a £~int band is seen in 
"purified" LC not exposed to L PS in Fig in (laff e I), w h ereas it is 
n ot seen in the XS-S2 cell s (Fig 1/,) . 
To con fi rm the occurrence of iN OS expression in LC and not in 
keratinocytes, R T -PCR was conducted on murine keratinocyte 
RNA as well. Primary murine keratinocytes were cultured in 
low-calcium m edium for 10 d b efore RN A was extracted and 
reverse transcribed. It is expected that after 10 d, in th e absen ce of 
GM-CSF, the cultures h ave n o LC prese llt, al t ho u g h keratinocytes 
grow well. PC R with iNOS-, ecNOS-, and n c NOS-sp ecifi c prim-
ers was ca rri ed o ut, and GA PDH-specific prime rs were used as 
control. Murine keratinocytes treated with LPS do not con ta in 
iNOS m essage but sh ow evidence of n cNOS m essage, w hic h is 
con siste nt with fi ndings in human ke ratillocytes (Baudoin and 
Tacho n , 1996). T h ese resu lts imply th at LC are a m aj o r sou rce of 
iNOS in the e pidermis. For a ll the above reactions, control reve rse 
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Figure 2. (A) XS-52 cells fluoresce with anti-iNOS in the presence of LPS. XS-S2 cell s were grown in chamber sljdes with and without LPS and 
stained with fluoresce in iso thiocyanate allti-iNOS. Staining is negligible in LPS (- ) cells, as compared to LPS (+ ) cells. Phase contrast images an! not shown 
for the sake of simplicity. (B) Immunoreactivity ofLallgerhans cells in intact skin. (i) Anti-iNOS immunoreactivity in newborn foreskin. showing 
Ilon-mclanocytic dendriti c ce ll s as the onl y immun oreactive cells ill the ep idermis. (i i) Shape and position of LC in skin of the same donor as in (i). identified 
by the C O-l antigen. The two sectiolls shown arc not se rial sections but morphology, loca tion of staining, and similarity between CD-1-stained and 
iN OS-sta ined sections is appa rent. There is nonspecific stai ning of erythrocytes (pseudoperoxidase of hemoglobin) in dermal vesse ls but no staining of 
endotheliul11 (bracketed vessel). Scale bars, 10 /1.111 . 
tran crip tase reac ti ons were ca rri ed o u t in the absen ce of reverse 
trancriptase en zym e, and no PC R prodllcts were ampli fied (data 
n ot shown). 
Detection of iNOS by Immunohistochemistry Immuno-
flu o rescence with flu o rescein iso thiocyanate- conjugated anti -i NOS 
monoclonal antibody in LPS-sti mul ated XS-S2 cell s sh owed 
m arked staining compared to ce ll s in cubated in LPS-frce m e dium 
(Fig 2A ). T he stainin g is cyto plasmic, spares the nucle us, and 
appears g ranular in som e cell s. T his resul t suggests th at LC express 
iNOS , which is induc ible by LPS. Stainin g of plll'ifi ed LC fi'om 
BALB/c epide rm al ce ll su sp en sio ns was n ot feasible becau se the 
magnetic microsphe res used for L C iso lation pre fere n t iall y pick up 
flourescein , even at maximal d iJu tions of the antibody. 
Human n eonatal fo reskin was fi'ozen and sectio n ed, and th e 
section s were stained w ith ;m ti-iN OS m o noclonal antibody, bind-
ing of which was detected by the av idin / bio t in-peroxidase m ethod . 
Dendritic, no n-melanocytic ce ll s were seen sta ining brig htly, scat-
tered in th e basal and suprabasa l e pidermis (Fig 2B-i) . T h ei r 
di stributio n was very simil ar to LC sta ine d o n sec tions of skin fro m 
the sam e source, using an anti -Leu6/CD-l antibody, w hich is 
se lective for human LC (Fig 2B-il). No o th er ce lls sta ined signi f-
icantly fo r iNOS. 
XS-52 Cells Produce NO iI/ Vitl'O Supe rna tants fro m XS-52 
cul tures were assayed for the presen ce of nitri te u sing the G riess 
reaction . Cell-fi-ee supernatants fi'om ce ll s incubated in the pres-
en ce of LPS showed a dramatic increase in nitrite concen tration, 
re fl ecti.n g th e increase in NO productio n . 1n contrast, cell s that 
were n ot stimulate d w ith LPS produced very sm all am o un ts of 
nitrite (Fig 3 iI/set) . IFNI' a lo ne did no t affec t NO pro du ction in 
XS-52 cells; however, w h en IFNI' (200 U p e r 1111) and LPS were 
adde d toge ther , NO productio n was in c reased to m o re th an 3 times 
that seen with L PS a lone (Fig 3 iI/set). T h erefore , LPS and lIoN y 
syn e rgisti ca lly increase NO produ ction. TNFO' h as been seen to 
induce NO pro duction in o the r sys tem s, but no e ffec t o n N O 
produc tion was observed in XS- S2 cells w he n TNFO' was added, 
e ither in the presen ce or absen ce of LPS . 
To es timate the time re quired fo r iN OS induction and subse-
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Figure 3. LPS and IFNy synergistically induce NO production in 
XS-52 cells. N O production increases over time in XS- 52 cells (50,000 
cells/well). iIl SCI , Nitrite levels of supernatants from XS-52 cell s after 
overnight incubation (200,000 cells/well) . NO production is seen to 
increase in the presence of LPS (1 f1.g per 1111) and is 111 0re pronounced in the 
the presence of LPS + IFNy (200 U per 1111). IFN I' docs not induce NO 
production in the absence of LPS in XS-52 cell s. 1, LPS( - ); 2, LPS( + ) 1 f1.g 
per 1111 ; J , IFNI' (200 U per ml) ; 4, LPS + IFN I' (200 U per ml)_ 
Expcdnlcilts were. pcrfo fll1ed in tripU ctlte for each variable . Mean valu es are 
shown with error ba rs::': SD. 
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Figure 4. Inhibition of NO production ill XS-S2 cells by L-NAME. 
Supernatants fro lll XS-52 cells incubated in 12-well plates overnight at 
n oC in L PS (I J-Lg per ml) alone and with L-NAME, all inhibit.or of iN OS, 
were assayed fo r nitrite levels usiJlg the Griess reactioll (200,000 cells/well ). 
1, LPS(-); 2, LPS(+) 1 J-Lg per 1111; 3, LPS + L-NAME (5 mM); oJ, LPS + 
D-NAME (5 mM) . Experiments were pertormed 0 11 three separate occa-
sions, and the bars represent an avcr:lgc of three wells o n a 1l1icrotitcr plate 
and are sh own with error bars (mcan ::!: SO). 
various timepoints. Supernatants w ere assayed fi'om individual 
wells at e;lch timepoint to prevent alteration in nitrite concentrati on 
due to sa mpling . and experim ents were performed in tt;plicate. A 
sma ll increase in nitrite levels is seen after 8 h bu t significant levels 
are obtain ed after 16 h (Fig 3) . 
Purified murine LC preparations w ere also assayed fo r nitrite 
levels after incubation in LPS. Although e levated njtt'ite levels are 
fo und in these cells, the results arc difficult to reproduce. Nitrite 
level s are not as high as those seen with XS- 52 cells , probably 
becau se these cells go through a difti cult purifi cation process, have 
magnetic spheres adhe ring to their surf.1ce, and arc fewer in 
number. It was not possible to o btain enough human skin to extract 
LC in s ufficien t numbers to m easure nitri te production . 
suppression of NO Production by L-NAME To confirm ill 
vitro NO production as seen in the previo us experiment, ni trite 
levels w-ere measured in the presence of LPS and the levorotatory/ 
dextrorotatory, m ethylated derivatives of L-arginine. Two com-
pounds were used: L-NAME, which competes with L-arginine for 
iNOS-binding sites and D-NAME, w hich is not a competitivc 
I inlUbitor, se rved as a contro l. Nitrite leve ls in supernatants fi'o m 
LPS- treated cells were used as contro l levels of NO production by 
XS-52 cclls. L-NAME inhibited NO production significa ntly in the 
presence ofLPS, whercas D-NAME did not (Fig 4). A titration of 
a range of LPS doses /lers lI .\' L-NAME doses was pcrformed. NO 
production increased as the dose of LPS in creased fi'om 0.01 JLg pe r 
ml to 1 }-Lg per ml , and this was observed at aU doses ofL-NAM.E. 
I Lower doses of L-NAME suppressed NO production better at the 
lower doses of LPS , and highe r amounts of L-N AME were required 
to suppress NO production at 1 JLg LPS per ml (data not shown) . 
This contirms that LPS-induced NO production in XS-52 cells can 
be inhibited specifica ll y by the L-mcthylated forms of L- arg injne. 
Suppression of NO Production by IL-IO T he cytokine IL- l 0, 
implicated in a varicty ofimmun om odula tory phenomena, has been 
shown to affect LC antigen presentation . IL-10 has also been 
observed to inhibit induction of iNOS expression by IFN I' and L PS 
in murine macrophages (Cunha et nl, 1992; Nathan, 1992). T he 
previous experiments address inhibition of NO production alone 
with no direct effect on iNOS, whereas lL-10 inhibits LPS-induced 
expression of iNOS. XS-52 cells co-cultured wi th IL-I0 and LPS 
reproduc ibly demonstra ted inhibition of ni trite production (> 80-
90%) in cell-free supernatants (Fig 5a) . 
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Figure 5. (a) IL-IO suppresses NO production ill XS-S2 cells . 
Cell-ti'ec supernatants 6'0111 XS-52 cell s incllbntcd in 12-well plntcs for 48 h 
at 3rC in the presence of LPS ( I J-Lg per ml) alone or LPS + lL- IO were 
ass"yed for the presence of nitrite using the Griess Reaction (200,000 
ce lls/well). IL-I O significantly suppresses LPS-induced NO production. 1. 
LPS(- ): 2, LI'S( + ) 1 J-Lg per ml; 3. LPS + IL-IO (35 ng per ml); 4. LPS + 
IL- IO (50 ng per ml) . Egual numbers of cells were plated per group, and aU 
bars arc shown with error bars (mean ::!: SD) . (II) IL-IO inhibits iNOS 
expression. Egu,,1 quantities of tota l protein extract fi'om XS-52 cells 
treated with LI'S. I L-I O. and L-NAME (in the doses indicntcd below) were 
separated via sodium dodeC)'1 sulfate-polyacrylamide gel electrophoresis on 
a 7%, ac rylamide gel and transtCrred to polyv inylidine fluoride membrnnes. 
The II1clI1brnnes werc probed with anti-iNOS antibodies. As a positive 
conn'o l, rota l protein extract fi'om LI'S- tre,ned mouse macrophag" ce ll s 
(RA \V264. 7 cells) was nll1 in lanc I. XS-S2 ce ll s without LPS treatment 
showed negligible iN OS expression (lalle 2), and the), delllonsrrar"d an 
increase in iN OS expression ill the presence of LPS (lallr J), which was 
inhjbi ted b)' IL-1 0 (/all e oJ). L-NAME and O-NAME do not affect iNOS 
levels in XS-52 cell s. /all('I, RA\Xf 26·L7 cclls(LPS); /aIII' 2, LPS( - ); /alle 3. 
LPS(+ ); /alle ~. LPS + IL-I O (50 ng per ml): /allC 5. LPS + L-NAME (5 
111M); /alle 6. LPS + O-NAME (5 mM). 
Effects of LPS, IL-10, and L-NAME on iNOS Expression 
Western blotting was used to characte rize iNOS levels in ce lls 
treated with [L-10 and L-N AME in the presen ce of LPS. Doth 
L-N AME and [L-10 inhibit NO production (as above), but their 
mechanism of action is difFerent. O n a western blot, probed with a 
monoclonal anti-iNOS antibody (Fig 5/,), protein Iysates fro m 
LPS-tre;lted cells appear to sh ow highe r levels of iN OS protein than 
Iysates fi'o l11 cells that were not exposed to LPS . Cells treated w ith 
both IL-10 and LPS, however, had lower iN OS levels, almost 
equi va lent to cells not tt'eated with LPS. T hese results suggest that 
IL-10 , but not L-N AME, prevented LPS-induced iNOS expression 
and that the inhibitory eftccts of IL-1 0 and L-NAME on N O 
produc tion in XS- 52 cells occur through djfFerent routes: [L-10 
inhibi ts iNOS express ion in XS- 52 cells whereas L-NAME inhibi ts 
conversion of L-arginine by iN OS in to NO. 
D ISCUSS ION 
T hese results demonstrate that the inducible fo rm of the enzyme 
NOS is present in LC and the LC-like cell line XS- 52. Expression 
of iN OS m es-,age was LPS-dependent in XS-52 cells, as in macro-
phages (Denis, 1994). In con trast, " unstimulated" newborn hum an 
foreskin and LC purified I]-om murine epide rmal cells express iN OS 
protein and a low level of iN OS message, respectively. T hese ce IJ s 
m ay ha ve been stimulated ill /l ill(' by exposure to an unidentifi ed 
antigen o r, in the case of the murine LC, activated dUl'ing isolation. 
I t is unlikely that endotoxjn in the m ed ium was responsible for 
expression of iN OS in these cells because they were cultured in 
medium that was serum-free with a negligible endotoxi.n content of 
< 0. 125 ng per ml and because the XS-52 cells were cu ltured in the 
sa m e medium and did not express iNOS in the absence ofLPS. The 
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possibility that th e PCR product amplified from purified LC was 
from a cell type o ther than LC, such as keratinocytes, was examin ed 
and a negative result obtained. 
T here are several potentially significant aspects of iNOS expres-
sion and NO production by LC. While the constitutive production 
of NO is important for basal m etabolic processes, it is the inducible 
form of the enzyme that results in massive production of NO and 
mediates effects ranging from antimicrobial to cytotoxic ones. 
T hus, in infections where the organism resides intracellularly, such 
as Leislllllallia, NO is a vital microbicidal agent in macrophages. An 
analogou s situation may apply to LC. In tumors, NO from ma cro-
phages has been shown to be cyto toxic, causing cell death both by 
necrosis and apoptosis (Shijun e/ (/1, 1994). LC have been implicated 
in tumor surveill ance in the skin , and the ro le of LC in tumor 
cytotoxicity with respect to NO should be considered . W ith 
respect to antigen presentation , depending upon the system, NO 
ca n enhance o r suppress responses (R.oland e/ ai, 1994). NO ha s a 
role in antigen presentation by dendritic cells and may affect LC 
antigen presentation in the epidermis (Becherel et ai, 1994). Being 
diffusible across ce1.1s, NO produced by LC may be anti-proli fera-
tive for Band T cells (Albina and H enry, 1991), or even pro-
proliferative for B cells by decreasing apoptosis (Genaro et ai, 1995). 
T he immune response could be modified after LC have successfuIJ y 
presented antigen to lymphocytes because NO may inhibit o r 
enhance lymphocyte responsiveness. IL-I0 suppresses NO produc-
tion in XS-52 cells, and it is known that IL-I0 inhibits anti gen 
presentation (Asahina e/ ai, 1995). Therefore, NO may mediate the 
effects of IL-lO, e .g., neutralization ofIL-IO effects with anti-IL-I0 
antibody upregulates NO production and has been shown to 
protect susceptible mice when challenged with Calldida all)iwlIs 
(R.omani el ai, 1994). 
It is likely that LC are the only epidermal cell imbued with the 
capacity to express iNOS. T his production of N O may have 
pathophysiologic consequences, som e of which may be beneficial , 
such as microbicidal and tumor surveillance, and others, which may 
be associated with inHal11111atory or other conditions. T he report 
that topical L-NAME could re li eve atopic dermatitis (Morita et ai, 
1995) is consistent with N O being involved in at least one 
inHammatol·y disease and will likely lead to studies of NOS 
inhibitors in other diseases . T he avai labili ty of mice that lack iN OS 
expression and the production of transgeni c animals that overex-
press NO in the skin will also help clarifY the cutaneous bio logy of 
NO. 
Hi e ",,,"Id like Ie> gralli"l/y ackllolldedg" Drs. Aamll B. Lem er alld Gisela 
Moe/lllln/III, Yale UlliJlcrsily School oj Met/icillc, ji". Ihe picillres Ih")l pnlllided of 
{III1'II'IIo-peroxidase slaillillx.lor LC Oil 111'"1011 sk ill as seell ill F(~ 2B. Hie are also 
grtlliifi d loJallice Brisscllefor her/,,'lp lIIilh preparalioll ojprilllary IIlI,rille keralillocy/e 
cu/",res. "r l,;s work was slIpported by nl1 agreemel1t be/wee" J\llasstll:/",selJs Gellcr,,1 
Hospilal alld (he Shiseido COlIIl'all)1 Lid. alld RO-l AR42005 (EAL) ami RO-l 
A R 42429 (RDG). 
REFERENCES 
Albin" J E, Henry W L: Suppression of lymphocyle proliferation through the nitric 
ox ide synthesizing p"thw")'.) SIII:~ Res 50 :403-409. 199 1 
Asahina A. l-I oso iJ . 13cisscrt S. Stratigos A. Granstcin R.D : Inhibition of the indu ctio n 
of delayed-type and contac t hypersensitivity hy ca lcitonin gene-related peptide. 
) fllllllll llol 154:3056-3061, 1995 
Asn hin " A, Moro 0 , HosoiJ, Lerner EA, Xu S, T"kashilll" A, Gr"nstein IUJ: Specific 
indu ction of cAM P ill Lnll g:c rh'lI1s ce lls by calci tonin gene-related peptide: 
relevan ce to fun ctional effects. PrOf N"II Acml Sri USA 92:8323-8327. 1995 
B:lUdol1inJ E. Tachon P: Constitu tive nitric m"';dc synthase is present in normal human 
kcratinocytes. J Ill vesl Denll" It)1 106:428 - 431, 1996 
Bccherc! PAt Mossalayi MD. O uailz F. le Goff L. D ug;1s U, P:IUI-Eugenc N , Fr:lI1 ccs 
C, C hosidow O. Ki lchhcrr E. Gui llossonj -J, Oehre p. Arock M: In volvement of 
cycl ic AMP and nitric ox ide in imllll111 og:lobuJjn E-dcpcndent activ:ttion of 
FccRJI /CD23 + norm al hUIl'l<lIJ kcratinocytcs.} e li" I" "l'st 93 :2275-2279. 1994 
Uecker Y: Success "nd nl ilure of dendritic cell (DC) anti cance r activity may be 
T H E J OURNAL OF IN VESTIGATIVE DERMATOLOGY 
modulated by nitric oxide synthetase (NOS) gene expression: " hypothesis. III 
IIi"" 7:285-288, ·1993 
C unha FQ. Moncada 5, Licw FY: Interlel1kin-10 inh ibi ts the induction of nitric oxide 
syn thase b y in terfcron-g:ltllJ11a in murine macrophages. Biaclll'lIl Bioplt}'s Res 
COII/l/llII ) 182:1 155-11 59. 1992 
C unh" FQ, Moss DW, Le"1 LMCC, Moncada S: Induction of l11 acropha ge p","siticid.1 
activil), by Srl1pli),/ l1COCC IIS ollr-ells and exotoxins through the nitric oxide synthesis 
pa th way. 11i1/I)))) /OI"SY 78 :563-567, 1993 
Delicollst:lI1tinos G, Villiotou V. Strav rides jC: R.elease by ultr;1 violct B (u.v.B) 
radiation of ni tric oxide (NO) fro l11 human kcratinocytes: :1 potential role for 
ni tri c ox ide in erythema producti on. nr) P//(/nllareJ / 114:l257- 1265 . 1995 
Denis M: Human monocytcs/mil crophngcs: NO or 11 0 NO?) Lc"ko[ Bioi 55:682-68-1. 
1994 
Edelman G M. Gail y J A: Nitric oxide: Iil1killg sp;lce and time in the brain. Pre)(' Natl Arad 
Sci USA 89:1 1651-11 652. '1992 
Ce llaro AM. Hortelallo S, Alvarez A, Martin eza C. Hosca L: Splenic 13 lymphocyte 
progr~llnmed cell dC~l dl is prevented hy nitric oxide releasc through mechanisms 
in volvin g sust" incd BcI-2 levels. ) elill IIII'es I95:1 884- 1890. 1995 
Gmbbe S, Bruvers S. Gall o ttL, Knisely TL. Naz"reno R. Granstein RD: Tumor 
:m.tigc n prcsel1wtiol1 b y llll1ri ne epiderm al cells. } 11I",,"/w/ 14u:3656-366 I . 1991 
Green LC. W"gner DA, Glogowski J, Sk ipper PL. Wishnok j S. Ta nn enba um SR: 
Analysis of nitrate. ni trite. and [ 15NJnitratc ill biologica l Allids . A I/ til Diorltem 
126:13 1-1 38, 1982 
Green, LC, Ruiz de Luzuriaga K, W"gllc r DA . Rand W, Istr., n N. Young YR. 
Tenn enbaum SR : N itrate biosynthesis in man. PI'(I[ N,,(I ACild Sri USA 78:7764-
7768. 1991 
!-Ieck DE, Laskin DL, G"rdner CR, Laski n j D: Epidermal growth lo ctor suppresses 
nitric oxide produ ction by kc rnrinoc)' tes. ) m,,1 C/ICIII 267:21277-2 1280. 1992 
Hen nin gs I-I. Midt:lel D. C heng C . Ste in ert p. H olbrook K. Yuspa SH: Calcium 
rcgul:ltio n of growth ~tI1d differentiation or mouse epidermal ce ll s in cul ture. Cell 
1 '):245-254, 1980 
I-Iosoi j , Murph y GI' , Ega n C L, Lerner EA , Grabbe S, Asa hina A. Gra llstcin ltD: 
Regulation or L:mgerh :m s ce n fu nction by nerves cOlltainin g ca lcitonin gcne-
re lated peptide. Nat llre 363: 159 -1 63. 1993 
Hughes SR. W ill imas TJ. Brain SJ) : Evidence thar: endogeno lls ni tric oxide modulates 
oedem" formation induced by sub""nce P. Ellr) I'ilnflllllwi 1 ~I :48 1-484, 1990 
Kap lan G. Walsh G. Guido LS. Me)'n P, Hurkh"rdr ItA. Au" los R.M. Bnrkcr J . Frindt 
PA. Fajardo TT. Celoml R: Novel responses of human skill to intradermal 
recombinant granu locyte/ macropha ge-colony-stiI1111Iating Gletor: Langcrh<llls 
cell rccruiml ell t. keratillocytc growth, and enhanced wound hC;11illg. } Exp l\ l ed 
17 17-1728. 1992 
Kapscnberg ML. TCl1 lli sSCIl MBM. Bas JO: Langcrhans ce lls: a unique subpopulation 
ofan tigcTl presenting dendritic ce lls. In : G'lll o R .. L, Gr:lI1 stc in RD. Staszc\Vsky H. ... 
"Oos JD (cds.) Skill 1111111111 11" S),slelll. CI1.C. Hoca Raton . FL, 1990. PI' 109-1 24 
Kh"n F. "alacino JJ. Cofm"n j D, Cohen RA: C hroni c inhibi tion of nitric oxide 
production augmcnts skin vasocollstriction in th e r:lbhit ear . .J Cnrdi/l/fasc Plrnr· 
,,,"col 22:280 - 286, 1993 
Ki mbe r I. C umbcrbatc h M : Dendri tic cl.! lIs and cut;1 l1eous immune responses to 
clt crnical .1I Iergcl1 s. Toxin)1 PllflnIUlro / 11 7:137- 14G. 1992 
Kolh-B:u:l1ofen V. Fehse l K. Michel G, R.uzicka T: Ep iderma l kcratinoC)'lc exprcssion 
of inducible nitric oxjdc synrh :lscs in skin lesions o f psoriasis vulgaris. L IlI/CCI 
344: 139,1994 
L:lIlcaslcr jr JR.: Si mulation o f rhe diff-i.lsion and re<lc tioll of e ndogenously produced 
nitri c oxide. I'roc Natl Acari Sri USII 9 1:8 137-8141 . 1994 
Liew I=Y, Cox FEG: Nonsped ti c defense mechanism: the role of t1itri c oxi dc. JlIllll fltltll 
Todll)' 12:A17-A2 1. 199 1 
Liew FY. Mill ott S, P"rkinson C. Pa lmer I1.MJ. MOl1c"da S: Macrop hage kill ing of 
Lcis hm:mi a p;1f<1site ill 11;'/ " is m ed iated by ni tri c oxide fro m L-a rginine.} 11111111",01 
144 :4794-4797. '1990 
Lippe IT, Sta bcnt ll eincr A, Holzer P: R.ole of ni tric oxide in the vasod il acor bur not 
exud:lti vc component of lI1ustard o il-induced inflammation ill rat skin . .rte( ~IIfS 
;Ir,i,"'5 38:C21-C23, 1993 
Lyons C R. O rl ofrGJ. Cun ningham JM : Molec ular cloning "nd ('lII etiol1al expression 
of;\I1 in ducible ni tric oxide synthases from II 11l1ll'in c nl<lcrophagc cell line.) Bioi 
Clw/)/ 267:6370-6374. 1992 
Milstein S, Saka i N, Ka ufma n S, Sa ito K, !-Icycs MP: l1.ole of tetrahydrobioptcrin in 
cYlok inc-stilllllla ted Inet;lbol.islll of trypl:Opllan al ld Il ydroxylation of arginine. 111: 
Ayling JE N (II (cds.) Chelllisr'li miff Biolo.~)1 of fJt cridi/lcs 111/(1 Foln tcs. Plenum Press. 
New York. 1993, PI' 289-294 
Morita H. SCl11 l11 :l M. Ho ri M. I<jtano Y: Clinical applications of nitric ox ide s)'ntllasc 
inhibitor for atopic derma titis. //11 J Demltlwi 34:294. 1995 
Nathan C: N irric oxide as ;1 secrcwry product of mamll1alian ce lls. FASEB) 
6:3051-3064 , 1992 
Nathan C. X ic Q-W: R egul ation of biosynthesis of nitric oKidc. J Bio/ Chelll 
269:13725-13728. 1994 
Palmer RM, Fcrrigc AG. Mon cada S: Nitric oxide releasc accoul1 t.~ for the biological 
activ it)' of endothelium-derived relaxing f"ctor. NIIII/r,· 327 :524 -526 , 1987 
Pcguet-Navarro J, Moulon C. Schmi rt D: The :lntige n presenting capacity of human 
epiderm"1 Lnngcrhans ce lls. Cdl Mol Bioi 40: 15-20. 1994 
Qureshi AA. Lerncr LH . Lenlcr EA: From bedside to the bench and b:l ck: nitric oxide 
and the cutis. IIrril Derlllalol. 132:889-893, 1996 
Ro land CR, Wa lp L. Stack 11.M , Flyc MW: Outcome of KupUcr ccl.l "ntigen 
preselltation to <l dOlled Illurine T ill lymphocyte depcnds on the inducibility of 
nitric oxide synth ase by IFN-g"ll1ma.) 11111111111111 153:5453-5464. 1994 
R Ol11ani L. Pu ccctti P. Mcncacci A, Cenci E, Spacca pcl o R . TOllnetti L. Grohman U. 
Bistolli 1=: NClltraliz;ttion of 1L- '10 up-regulates nitric oxide production and 
VOL. 107, NO.6 DECEMB ER 19% 
protects susceptible mi ce fro m challenge w ith Candida alhic;1I1s. J 1,Il IlIUII O/ 
1 52:35 14-352 1. 1994 
Shjjun C . R.cichn cr J S. Matco tW. Alhilt;l J E: Activated mu rine mil crophages indu t.:c 
apoptosis in ClIlllo r ce lls throu gb ni tric oxide-dependent Of - independellt. mech-
a ni sm s. Calla.,. u' rs 5-1:2462-2 -1 67. 11)94 
SiJbe rbe r g-S in akin I. T ho rbcckc GJ. note r RL. Rose nthal SA. I3crczowsky V: Antigcn-
b ea ring L;m gcrhans cell s ill sk in , de rmal lymphocytes i.tIld in lymph nodes. Cdl 
111111111110/25: 137-15 1. 1976 
Sn yder S I-I , Bredt DS: Biological ro les of llitric oxide. Sri .-1111 5:(,8-77. 1992 
Sta m le r J S. Singel DJ . Loscalzo J: Biochemistr), o f ni tric oxide alld its redox-activa led 
-forms. Sci""f/' 258: 1898 - 191l2. 1992 
SCciJ1",an R.M : T he dendritic cell syste m and its ro le in il11ll1ullogcniciry. A liI/II RCII 
111111111/10/ 9:27 1- 296. 199 1 
Stingl G: Delldrilic ce lls o f the ski ll . Dalllat,,1 Clill 8:673-679. 1990 
Takashima A. Ec1elb, lIIll D. Kit"jima T . Shadd lick RK. Gilmo re GL. X u S, Taylor R S. 
B e r gstresser PRo AriizlIll1i K: Co ion y-stillltli ating facto r- I sl.!crc[cd by fib rohlasts 
N ITRIC O XIDE IS PRODUCED BY LANGERI-IANS CELLS 821 
pro motes the growth of dendritic ccJl lili es (XS series) derived from murine 
cpid~nnis.J 11III1IlIIw l 154:5 '128-5 '135, 11)1)5 
W :lIlg R. Ghahary A, She ll YJ . Scott PG. T rcdgct EE: 1-IUII1:111 derm al fibrobl;., sts 
produ ce nitric oxide and express hoth the constitutive and indu cible nitric oxide 
synthase iso fnrl1ls.J .l11l1f.\" Der", arll l 106:-41 9- -1 27. 1996 
\Varrcl1 JB: Nitric oxide and human skin blood Row responses to ace tylcho line all d 
ultraviolet light. FA SEB J 8:247-25 1. 1994 
Xu S. Ariiz111l1 i K. Caccfl!s-Dittl11ar C. Edclhaul11 D. H:lshimoro K. Bergstresser PR, 
Tak:lshil11 :1 A: Successive gCll cr;ltio ll of antigell-presellting. dendritic cell lines 
from lIlurine epide rmis . J / IIIIIIIOfll/ 154:2697- 2705 . 199501 
X u S. Ariiz ul1Ii K. EdclbaullI D . Be rgstresser PRo T;:.k:1Shil1l:l A: CYlOkine-dcpclldcll t 
rcg ul;:.ti o n growth and 1lI:ltur3tion in murin c epiderm al delldriti c ccll lill t!s. Ell ,. 
J 1111111111,,'/25: 10 18-1024, 1995b 
Xic QW , C ho I-IJ. Ca l,,),ca), J . Mumfo rd R , Swiderek KM. Lee T B. Ding A. Troso T. 
Nathil ll C: C loning and charac[c riz:t tio ll of inducible nitric ox:ide synthase fro m 
mouse m 'lcrophagc. ScicHce 256:225-228. 1992 
